Drug Shortage Report for MULTI 12 INJECTION

Last updated on 2022-02-04 History
Report ID 148854
Drug Identification Number 02100606
Brand name MULTI 12 INJECTION
Common or Proper name MULTI 12 INJECTION
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) VITAMIN B12 FOLIC ACID BIOTIN VITAMIN E DEXPANTHENOL PYRIDOXINE HYDROCHLORIDE NICOTINAMIDE VITAMIN B2 VITAMIN B1 VITAMIN D VITAMIN A ASCORBIC ACID
Strength(s) 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2 x 25mL vial set
ATC code B05XC
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-04
Estimated end date 2022-07-29
Actual end date
Shortage status Actual shortage
Updated date 2022-02-04
Company comments Baxter Product code : 6420
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-11-04 English Compare
v2 2021-11-04 French Compare
v3 2021-11-05 English Compare
v4 2022-02-04 English Compare
v5 2022-02-04 French Compare

Showing 1 to 5 of 5